TrippBio Announces Agreement with NIAID to Evaluate PanCytoVir™
13 Sep 2022 //
APNEWS
TrippBio announces publication data supporting the antiviral potency of TD-213
26 May 2021 //
PRWEB
TrippBio Reports Positive Results from Investigator-Initiated Trial of TD213
16 Nov 2020 //
PRNEWSWIRE